1 Followers SHG:603392 - Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Beijing Wantai Biological Phar
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2013 Q4	2014 Q4	2015 Q4	2016 Q4	2017 Q4	2018 Q2	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	88.51% 0.5%	89.06% 0.6%	88.59% -0.5%	87.41% -1.3%	86.28% -1.3%	82.89% -3.9%	83.46% 0.7%	83.45% 0.0%	83.45% 0%	83.12% -0.4%	83.12% 0%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	33.23% 6.4%	32.14% -3.3%	35.15% 9.4%	37.83% 7.6%	41.1% 8.6%	44.21% 7.6%	42.34% -4.2%	42.66% 0.7%	39.76% -6.8%	34.65% -12.8%	22.64% -34.7%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	84.09% 1.1%	85.61% 1.8%	85.78% 0.2%	87.46% 2.0%	87.98% 0.6%	88.71% 0.8%	89.54% 0.9%	90.04% 0.6%	90.06% 0.0%	88.54% -1.7%	85.63% -3.3%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	39.97% 4.8%	39.02% -2.4%	42.37% 8.6%	47.01% 10.9%	50.73% 7.9%	53.18% 4.8%	50.06% -5.9%	49.19% -1.7%	44.36% -9.8%	36.39% -18.0%	29.43% -19.1%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.47B 21.2%	4.35B 25.2%	5.75B 32.2%	8.1B 40.8%	9.72B 20.0%	10.8B 11.2%	11.19B 3.5%	10.9B -2.5%	9.42B -13.6%	7.5B -20.3%	5.51B -26.6%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.41B 12.8%	5.49B 24.4%	7.05B 28.4%	9.12B 29.4%	14.05B 54.0%	15.22B 8.3%	16.23B 6.7%	17.25B 6.3%	16.48B -4.5%	16.46B -0.1%	15.71B -4.6%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.21B 16.6%	1.8B 49.1%	2.48B 38.1%	3.17B 27.6%	3.37B 6.2%	3.47B 3.1%	3.66B 5.6%	3.48B -5.1%	3.09B -11.2%	2.97B -3.8%	2.83B -4.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.17B 11.4%	3.63B 14.7%	4.47B 22.9%	5.8B 29.8%	10.5B 81.1%	11.55B 10.1%	12.34B 6.8%	13.59B 10.1%	13.2B -2.9%	13.31B 0.8%	12.7B -4.6%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	724.97M -	-	1.68B -	-	3.03B -	-	4.13B -	-	2.58B -	-	1.54B -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	653.54M 204.7%	659.1M 0.9%	701.46M 6.4%	587.02M -16.3%	707.52M 20.5%	684.63M -3.2%	1.41B 106.4%	1.61B 13.6%	5.37B 234.5%	4.66B -13.3%	5.19B 11.3%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	723.23M -0.2%	692.43M -4.3%	1.41B 104.1%	1.62B 14.4%	5.36B 231.4%	4.63B -13.7%	5.19B 12.1%	4.33B -16.4%	3.68B -15.1%	3.65B -0.7%	3.78B 3.6%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	75.65M 15.5%	33.29M -56.0%	634.16M 1804.7%	887.12M 39.9%	1.85B 108.2%	2.89B 56.3%	3.2B 11.0%	2.36B -26.4%	1.57B -33.3%	1.06B -32.7%	378.15M -64.2%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.16B -	-	2.08B -	-	4.13B -	-	4.86B -	-	3.79B -	-	1.25B -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.999 34.5%	1.146 14.8%	1.64 43.1%	2.483 51.4%	3.24 30.5%	3.848 18.7%	3.793 -1.4%	3.7 -2.4%	2.943 -20.5%	2.053 -30.2%	0.99 -51.8%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	43.68% 9.0%	46.8% 7.1%	57.59% 23.1%	70.91% 23.1%	58.44% -17.6%	62.91% 7.6%	56.35% -10.4%	47.98% -14.9%	31.61% -34.1%	20.92% -33.8%	9.96% -52.4%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	31.91% 8.7%	32.26% 1.1%	38.32% 18.8%	47.03% 22.7%	43.27% -8.0%	46.15% 6.7%	40.69% -11.8%	35.26% -13.3%	24.54% -30.4%	16.42% -33.1%	7.81% -52.4%